GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inovio Pharmaceuticals Inc (MEX:INO) » Definitions » Non Operating Income

Inovio Pharmaceuticals (MEX:INO) Non Operating Income : MXN24.18 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Inovio Pharmaceuticals Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Inovio Pharmaceuticals's Non Operating Income for the three months ended in Sep. 2024 was MXN21.17 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Sep. 2024 was MXN24.18 Mil.


Inovio Pharmaceuticals Non Operating Income Historical Data

The historical data trend for Inovio Pharmaceuticals's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inovio Pharmaceuticals Non Operating Income Chart

Inovio Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -82.19 -664.75 -70.43 -265.28 -146.00

Inovio Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -183.16 14.48 -5.10 -6.38 21.17

Inovio Pharmaceuticals Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN24.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inovio Pharmaceuticals Non Operating Income Related Terms

Thank you for viewing the detailed overview of Inovio Pharmaceuticals's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Inovio Pharmaceuticals Business Description

Traded in Other Exchanges
Address
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA, USA, 19462
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.